Clinical Trial Update: Rapid Early Action for Coronary Treatment (REACT) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Rapid Early Action for Coronary Treatment (REACT) has completed, with no results provided in the document.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Heart Disease
• Ischemic Heart Disease
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: Carelon Research | Conditions: Cardiovascular Diseases, Coronary Disease | Phase 3 | Status: COMPLETED